Yale Spinout, Cybrexa Therapeutics, to Debut Preclinical Data Demonstrating CBX-15 is Safe and Highly Efficacious in 13762 Triple Negative Breast Cancer Model
Guideli, founded by Harvard and Yale MBA students, plans to help immigrants settle down in their new countries
Yale Start-up Tetricus Gets Seed Investment to Commercialize Machine Learning Platform for Mental Illness Diagnosis and Treatment
Yale Spinout, Osmol, Gets Approval to Initiate First-in-Human Phase 1 Clinical Trial of OSM-0205 for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)
